Spire Wealth Management Sesen Bio, Inc. Transaction History

Spire Wealth Management

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 03, 2023	BUY	$0.49 - $0.61 $490 - $610	1,000 New	1,000 $1,000
Q2 2022 Jul 22, 2022	SELL	$0.38 - $0.89 $380 - $890	-1,000 Reduced 50.0%	1,000 $1,000
Q1 2022 Apr 18, 2022	BUY	$0.58 - $0.86 $115 - $172	200 Added 11.11%	2,000 $1,000
Q2 2021 Jul 26, 2021	BUY	$2.18 - $4.66 $2,616 - $5,592	1,200 Added 200.0%	1,800 $8,000
Q1 2021 May 21, 2021	BUY	$1.3 - $3.24 $780 - $1,944	600 New	600 $2,000

Ticker SESN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 201,702,000
Market Cap $127M
Description
Sesen Bio, Inc., a late-stage clinical company, focuses on designing, engineering, developing, and commercializing targeted fusion protein therapeutics (TFPTs) for the treatment patients with cancer. Its lead product candidates include Vicineum, a locally-administered targeted fusion protein that is in Phase III clinical trials for the treatment...

Get notified when there are updates to the investment portfolio of Spire Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Spire Wealth Management with notifications on news.